Nostics provides a handheld diagnostic platform that uses Raman spectroscopy and AI‑driven Large Spectral Foundation Models to identify bacteria and fungi directly from patient samples in under ten minutes. The portable, cartridge‑based system delivers lab‑comparable, species‑level results at the point of care without requiring laboratory expertise, enabling immediate, data‑driven treatment decisions.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current microbiology diagnostics rely on centralized laboratories, requiring culture steps and days to deliver results. This delay forces clinicians to prescribe empirical antibiotics, contributing to misdiagnosis, ineffective treatment, and rising antimicrobial resistance.
Solution
Nostics offers a handheld diagnostic platform that identifies bacteria and fungi directly from patient samples in under ten minutes. The system combines Raman spectroscopy with nanostructured metal substrates to amplify molecular signals from viable microorganisms, eliminating the need for culture. Proprietary Large Spectral Foundation Models powered by artificial intelligence interpret the resulting spectral fingerprints to deliver species‑level identification. The device uses disposable, easy‑to‑load cartridges, enabling point‑of‑care testing in clinics, urgent‑care centers, and remote settings without laboratory expertise. Real‑time results support immediate, data‑driven antibiotic selection, improving patient outcomes and supporting antimicrobial stewardship.
Target Audience
Primary customers are healthcare providers operating at the point of care—such as primary care physicians, urgent‑care clinics, and community health centers—as well as laboratory networks seeking rapid, decentralized testing solutions.
Features
- Raman spectroscopy provides high‑specificity molecular fingerprints of pathogens.
- Nanotechnology‑enhanced substrates boost signal strength for direct detection from clinical samples.
- AI‑driven Large Spectral Foundation Model classifies pathogen spectra, with few‑shot learning to add new organisms quickly.
- Portable, battery‑operated hardware with user‑friendly cartridge loading requires no lab skills.
- Automated workflow delivers species‑level results in <10 minutes with lab‑comparable accuracy.
- Cloud‑connected analytics enable secure data storage and integration with electronic health records.